News Room

Health Bulletins

Compassionate Review Drug Policy Expanded

Ontario Providing Greater Access To Critical Drugs

January 21, 2011

Ontario is expanding its compassionate review policy so that more patients with rare clinical circumstances can potentially benefit from coverage under Ontario Public Drug Programs (OPDP).

As of January 19, 2011, the Executive Officer of the OPDP will consider requests to cover drugs in cases where an individual has been urgently hospitalized due to an immediate life, limb or organ-threatening condition and the requested drug therapy is directly related to the condition that resulted in the hospitalization. Interim coverage of the drug will be for a maximum period of six months and will begin once the patient is discharged from hospital.

The province will consider covering drugs that have been reviewed by the Committee to Evaluate Drugs (CED) and where Ontario is in funding negotiations with the manufacturer. Previously, applicants could not be approved for coverage in cases where the CED had made a recommendation, but the ministry was still in negotiations with the manufacturer.

The expanded policy responds to a recommendation from a 2010 report of the Ontario Citizens´ Council on funding for drugs for rare diseases.



Read more about Ontario Public Drug Programs.
Read more about the Ontario Citizens´ Council.
Read more about the Exceptional Access Program

For More Information

If you are a reporter with a question for a story, or with comments about how this News Room section could serve you better, send us an e-mail at:

Media Line
Toll-free: 1-888-414-4774
In Toronto: 416-314-6197

Public Inquiries
Call ServiceOntario, Infoline
at 1-866-532-3161
TTY 1-800-387-5559.
In Toronto, TTY 416-327-4282
Hours of operation : 8:30am - 5:00pm